rs73373171
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_003803.4(MYOM1):c.2384+4A>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000493 in 1,607,898 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_003803.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM1 | ENST00000356443.9 | c.2384+4A>T | splice_region_variant, intron_variant | Intron 16 of 37 | 1 | NM_003803.4 | ENSP00000348821.4 | |||
MYOM1 | ENST00000261606.11 | c.2384+4A>T | splice_region_variant, intron_variant | Intron 16 of 36 | 1 | ENSP00000261606.7 |
Frequencies
GnomAD3 genomes AF: 0.00264 AC: 401AN: 152164Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.000701 AC: 173AN: 246684Hom.: 1 AF XY: 0.000531 AC XY: 71AN XY: 133798
GnomAD4 exome AF: 0.000269 AC: 391AN: 1455616Hom.: 1 Cov.: 31 AF XY: 0.000234 AC XY: 169AN XY: 723040
GnomAD4 genome AF: 0.00264 AC: 402AN: 152282Hom.: 3 Cov.: 32 AF XY: 0.00267 AC XY: 199AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Splice site variant (c.2384+4 A>T) in the MYOM1 gene Based on the information reviewed below, we categorize it as a VUS, probably benign due to its frequency in African Americans in population datasets. (Our patient is African American.) The c.2384+4 A>T variant is located in intron 16 of the MYOM1 gene, four nucleotides after exon 16. This variant was previously reported in the SNPDatabase as rs73373171. Based on data from the NHLBI Exome Sequencing Project (ESP), the T-allele has an overall frequency of approximately 0.23% (23/9,826), having been observed in 0.73% (23/3,154) of African American alleles, and in 0.0% (0/6,672) of European American alleles. Based on data from the 1000 Genomes Project, the A-allele has an overall frequency of approximately 0.23% (5/2,188). The highest observed frequency was 3 of 194 (1.55%) Luhya West African chromosomes studied. Based on nucleotide sequence alignment in 37 available vertebrate species, this nucleotide position is conserved in 35 of them. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native donor splice site; however, direct evidence of the effect on splicing is unavailable. -
c.2384+4A>T in intron 16 of MYOM1: This variant is not expected to have clinical significance because it has been identified in 1.0% (98/9464) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs73373171). -
MYOM1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hypertrophic cardiomyopathy Benign:1
- -
Cardiovascular phenotype Benign:1
Does not segregate with disease in family study (genes with incomplete penetrance);Subpopulation frequency in support of benign classification -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at